Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 13:30 source : Www.inovio.com save search
INOVIO to Present at Oppenheimer’s 32nd Annual Healthcare Conference
Published: 2022-03-08 (Crawled : 13:30) - inovio.com
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 2.3%
H: 8.49%
C: 4.49%
health thc conference
INOVIO to Report Fourth Quarter and Year-End 2021 Financial Results on March 1, 2022
Published: 2022-02-15 (Crawled : 13:30) - inovio.com
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 2.76%
H: 3.88%
C: 3.28%
financial results report results
INOVIO Highlights Key Updates on Phase 3 Program for VGX-3100, its DNA-based Immunotherapy for the Treatment of Cervical HSIL Caused by HPV-16 and/or HPV-18
Published: 2021-12-14 (Crawled : 13:30) - inovio.com
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: -1.56%
H: 0.67%
C: -1.34%
vgx-3100 treatment hpv immunotherapy therapy phase 3
INOVIO Announces Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 Variants
Published: 2021-11-30 (Crawled : 13:30) - inovio.com
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: -8.71%
H: 0.0%
C: 0.0%
sars-cov-2
INOVIO Collaborates with GuardRX and Geneva University Hospitals for Heterologous Booster Clinical Trial of its Ebola DNA Vaccine Candidate, INO-4201
Published: 2021-11-16 (Crawled : 13:30) - inovio.com
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
vaccine trial
INOVIO to Give Eight Presentations at the 34th International Papillomavirus Conference
Published: 2021-11-15 (Crawled : 13:30) - inovio.com
INO 4 d | $9.68 -5.1% -5.37% 350K
|
Health Technology
|
| O: 3.97%
H: 0.0%
C: 0.0%
presentation conference
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.